Clinical trial

GSK2190915 Moderate to Severe Asthma Study

NCT00850642

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-06-26

PhasePHASE2

Study timeline

Study start (actual)2009-06-26Date precision: day

Registry last updated2020-11-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

GSK2190195 100mgDRUG

PlaceboDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom1 MontrealQuebec, Canada1 ManchesterUnited Kingdom1 HamiltonOntario, Canada1 KingstonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00850642 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.